Pain medicine : the official journal of the American Academy of Pain Medicine
-
To systematically identify and appraise the current literature of pregabalin in the treatment of neuropathic pain resulting from cancer or cancer treatment. ⋯ There were limited published data reporting efficacy and safety outcomes for pregabalin in the treatment of neuropathic pain in adult patients with cancer. Due to limitations within the studies included in this review, it is not possible to draw any conclusions on the descriptive summary of pregabalin for the treatment of cancer-related neuropathic pain, and further studies are required.
-
To describe postoperative pain within the first 24 hours after pediatric otolaryngologic surgery and to identify factors influencing postoperative pain. ⋯ QUIPSI is an easy tool to evaluate the quality of postoperative pain management following pediatric otolaryngologic surgery in children older than 3 years, especially in children older than 9 years. The maximal pain values within the first 24 hours are significant, so that pain therapy is required. It seems that both nonopioids and opioids are underdosed.
-
Review Case Reports
Increasing back and radicular pain 2 years following intrathecal pump implantation with review of arachnoiditis.
Implanted intrathecal drug delivery pumps are now regularly used for the treatment of chronic benign and cancer-related pain that is refractory to conservative treatment methods. In most cases, the pumps are successful at reducing the intensity of pain and improving function and quality of life for pain patients. Limited studies have discussed the complications associated with intrathecal pump placement. ⋯ The entire IDDS was removed including the retained Touhy introducer needle. The patient later went on to receive a successful spinal cord stimulator trial and implantation with moderate relief of her chronic pain.
-
Observational Study
Pain assessment in patellar tendinopathy using pain pressure threshold algometry: an observational study.
Assessing pain in patellar tendinopathy (PT) is difficult to perform in a standardized way. With this study, we measured pain in athletes with PT by means of pain pressure threshold (PPT) algometry in a standardized manner. Subsequently, the goal of this study is to determine normative values for clinical use. ⋯ PPT algometry should be considered by clinicians as a pain assessment tool in patients with PT. The optimal cut-off point for the PPT to distinguish between PT athletes and healthy athletes was 36.8 N.